SREK1 (Gene)

Synonyms:ENTREZ:140890, HGNC:17882, MIM:609268, NM_001077199, NM_001270492, NM_001270493, NM_001323527, NM_001323529, NM_001323533, NM_001323534, NM_001323535, NM_139168, NP_001070667, NP_001257421, NP_001310456, NP_001310458, NP_001310462, NP_001310463, NP_001310464, NP_631907, SFRS12, SREK1, SRrp508, SRrp86, XM_011543171, XM_017009055, XM_017009056, XP_011541473, XP_016864544, XP_016864545, XR_948236, splicing regulatory glutamic acid and lysine rich protein 1
Omim:OMIM:609268
Id:ENSG00000153914
Hgnc:HGNC:17882
Entrez:140890
Description:splicing regulatory glutamic acid and lysine rich protein 1
This gene encodes a member of a family of serine/arginine-rich (SR) splicing proteins containing RNA recognition motif (RRM) domains. The encoded protein interacts with other SR proteins to modulate splice site selection. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SREK1's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SREK1.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SREK1.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SREK1.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SREK1.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.